Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... "Optimal implementation of adoptive T-cell therapy for cancer will likely require multiple and maintained genetic modifications of the infused T cells ... a frequency that could be increased to over 85% by selection of a transgenic surface marker (truncated CD19). PiggyBac could also deliver transposons of up to 13 kb with ...
2009 NOV 23 ... and response duration." Kim and colleagues published their study in Breast Cancer Research and Treatment (Clinical significance of a serum CA15-3 surge and the usefulness ... The researchers concluded: "These kinetics may serve as a good predictive marker of treatment response and response duration." Kim and colleagues published ...
2009 NOV 23 ... Biological Chemistry, Biomedical Engineering, Biomedicine, Biotechnology, Cancer, Heparin, Odontogenic Tumors, Oncology, Therapy, Tissue Engineering, Treatment, Kyushu ... inhibitors p21 and p27 was increased. We also found that the expression of enamelin, a marker of differentiated ameloblasts, was induced, suggesting that AMBN promotes odontogenic ...
2009 NOV 23 ... Gastroenterology, HBV, HCV, Hepatitis B Virus, Hepatitis C Virus, Hepatocellular Cancer, Hepatocellular Carcinoma, Hepatology, Histology, Infectious Disease, Oncology, VEGF, ... one case was negative. In most tumors specific hepatocyte antigen Hepatocyte Paraffin 1 marker (Hep Par 1) was mainly positive with markedly decreased reaction compared to the normal ...
2009 NOV 23 ... of methylated DNA in serum or plasma has been suggested to be a marker for early cancer development. We examined methylation changes in RASSF1A, a growth regulatory gene in ...
2009 NOV 23 ... in embryonic development. Dickkopf-1 is also implicated in osteoporosis, arthritis, and cancer and represents a potential therapeutic target for the treatment of these diseases," ... "Dickkopf-1 protein detection using enzyme-linked immunosorbent assay as a molecular marker can contribute to the detection and the diagnosis of cervical and endometrial cancers, ...
2009 NOV 24 ... mouse preadipocytes, polarizing human neutrophil-like cells and dividing human cancer cells.' This article was prepared by Science Letter editors from staff and ... from replicate experiments, in which cells were labeled with different but overlapping marker sets. We applied our approach to identify molecular differences among subpopulations and ...
2009 NOV 23 ... membrane integrity. Down-regulation of HP, TSA, and TGAGs seems to be a prerequisite for cancer development. This might be stimulated by up-regulation of free cathepsin D activity. ... and liver histology. Serum alfa-fetoprotein (AFP) level was used as an early marker for HCC in two groups of Wistar rats. One group of rats served as control and was ...
2009 NOV 23 ... (PET) provide a noninvasive method for improved staging and monitoring of response to cancer treatment. We evaluated prospectively the proliferation marker 3'-deoxy-3'[18F] ...
2009 NOV 23 ... IGFBP2 expression was also observed in human glioma tissue samples and in 90 different cancer cell lines by using Western blotting and reverse-phase protein lysate arrays. When ... IGFBP2, which contributes to glioma progression, thereby implicating IGFBP2 as a marker and potential therapeutic target for Ink4a-Arf-deleted gliomas." Moore and ...
2009 NOV 23 ... Germany conducted a study "To show discriminative power between patients with prostate cancer (PCa) and those with ''no evidence of malignancy'' using ''benign'' ... volume (0.69), and BPHA/tPSA (0.69) were significantly lower. Although BPHA as single marker or ratio to tPSA did not improve the diagnostic performance of %fPSA or tPSA, the ...
2009 NOV 23 ... internal malignancy. No association was found between seborrhoeic keratoses and cancer. Furthermore, our data did not provide support to the validity of the Leser-Trelat sign ... sign, defined as the eruption of numerous seborrhoeic keratoses as a cutaneous marker of an underlying internal malignancy. No association was found between seborrhoeic ...
2009 NOV 23 ... -4 and polymorphism frequencies of MMP-9 C1562T and plasma MMP-9 enzyme activity in lung cancer patients. In this study, DNA and RNA samples were extracted from peripheral blood of 300 ... of MMP-9 enzyme levels and expression of MMP-2 and -9 and TIMP-1 can be used as a marker in lung cancer." Bayramoglu and colleagues published their study in ...
2009 NOV 23 ... hematologic profile can predict the prognosis of patients with head and neck cancer. Medical records from 278 patients with head and neck cancer were reviewed, and 270 ... concluded: "A pretreatment hematologic profile can be considered as a useful prognostic marker in patients with head and neck cancer." Chen and colleagues published the ...
2009 NOV 23 ... "Paclitaxel is a chemotherapeutic agent used for the treatment of metastatic breast cancer. 2,5,7,8-Tetramethyl-2R-(4R, 8R-12-trimethyltridecyl) chroman-6-yloxyacetic acid (a-TEA) ... significantly decrease total number of cells staining positive for the endothelial cell marker CD31 or for the Ki67 marker of cellular proliferation and increase the number of ...
2009 NOV 23 ... F-18-fluorodeoxyglucose (FDG) in patients with follow-up or suspected recurrent biliary cancer in a multicenter study. We performed a retrospective review of 50 patients who underwent ... "Recurrence was suspected in 40 of these patients on the basis of tumor marker levels, and/or findings of conventional imaging (group A). Clinical findings in the ...
2009 NOV 23 ... at codons 248 and 249 of p53 gene showed a relatively high incidence in gastric cancer patients. Development of novel methods for the detection of codon mutations is of great ... matrixes to separate small size fragments (less than 70 bp) of pBR322/BsuRI DNA Marker and the separation conditions were optimized. Optimum separations were performed at 25 ...
2009 NOV 23 ... "Nonsmall cell lung cancer (NSCLC) is the most common type of lung cancer, which is one of the most prominent ... (Discovery of Retinoblastoma-Associated Binding Protein 46 as a Novel Prognostic Marker for Distant Metastasis in Nonsmall Cell Lung Cancer by Combined Analysis of Cancer Cell ...
2009 NOV 23 ... play critical roles in diverse chronic diseases, including parasite infections, cancer, and allergic responses. However, little is known about the acquisition and maintenance ... scientists in the United States report. "We report that M2-macrophage marker genes are epigenetically regulated by reciprocal changes in histone H3 lysine-4 (H3K4) ...
2009 NOV 23 ... are associated with poor overall survival in renal cell carcinoma patients. (Cancer Epidemiol Biomarkers Prev 2009;18(10):2685-93)." Zhang and colleagues ... patients. Our results suggest that SAM68 could represent a novel and useful prognostic marker for renal cell carcinoma," wrote Z.L. Zhang and colleagues. The ...
